Eagle Pharmaceuticals, Inc.

EGRX · OTC
Analyze with AI
Key StatsIncome StatementBalance SheetCash Flow
AnnualQuarterly
KMB
3/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets––––
Cash & Equivalents–$55,321$97,659$103,155
Short-Term Investments–$0$0$0
Receivables–$73,440$41,496$51,117
Inventory–$47,794$21,908$8,075
Other Curr. Assets–$3,259$6,712$1,605
Total Curr. Assets–$188,754$172,606$166,065
Property Plant & Equip (Net)–$1,168$1,636$2,077
Goodwill–$45,033$39,743$39,743
Intangibles–$118,327$10,671$12,917
Long-Term Investments–$10,011$0$12,200
Tax Assets–$27,146$18,798$15,180
Other NC Assets–$15,721$10,278$5,008
Total NC Assets–$217,406$81,126$87,125
Other Assets–$0$0$0
Total Assets–$406,160$253,732$253,190
Liabilities––––
Payables–$18,993$16,431$6,268
Short-Term Debt–$6,250$25,607$8,000
Tax Payable–$5,182$0$0
Deferred Revenue–$0$25,363$0
Other Curr. Liab.–$10,842-$7,885$0
Total Curr. Liab.–$111,087$74,376$38,085
LT Debt–$56,216$0$25,135
Deferred Rev, NC–$0-$1,751-$5,892
Deferred Tax Liab, NC–$0$1,751$1,933
Other NC Liab.–$3,789-$1$3,959
Total NC Liab.–$61,513$2,903$29,094
Other Liabilities–$0$0$0
Cap. Leases–$1,534$4,213$3,959
Total Liabilities–$172,600$77,279$67,179
Equity––––
Pref Stock–$0$0$0
Common Stock–$18$17$17
Retained Earnings–$111,504$75,862$84,489
AOCI–-$1,112-$94$0
Other Equity–$0$0$0
Total Equity–$233,560$176,453$186,011
Supplemental Information––––
Minority Interest–$0$0$0
Total Liab. & Tot. Equity–$406,160$253,732$253,190
Net Debt$0$7,145-$72,052-$70,020